Mary Roberts, MPH

Senior Vice President, Market Access Strategy

mary.roberts@advi.com

Life at ADVI Health:

Mary is responsible for leading ADVI’s Market Access strategy and solution team. Mary brings her clients over 25 years of experience developing comprehensive access and reimbursement strategies and tactics across multiple therapeutic areas and settings of care. She is focused on growing brand profitability and driving patient and provider confidence at launch and throughout a product’s lifecycle.

Life Pre-ADVI Health:

Before joining ADVI, Mary served as vice president, market access strategy at GSK and was the vice president and head, US and global value, access and policy at MorphoSys. Mary has led market access focused teams at numerous pharmaceutical companies including GSK, MorphoSys, Eisai, Roche, and Biogen as well as spent over five years in consulting advising pharmaceutical and biotech companies on market access strategy.

Life Beyond ADVI Health:

Outside of ADVI you will find Mary organizing a Girl Scouts adventure, cheering on the mountain biking team, leading a community event, driving to a dance competition, or (if she’s lucky) getting some much-needed rest from her busy family life.

Full Bio

Mary is responsible for leading ADVI’s Market Access strategy and solution team. Mary brings her clients over 25 years of experience growing brand profitability, developing actionable strategic plans, and leading successful access initiatives across the pharmaceutical industry. She has spent her career developing comprehensive access and reimbursement strategies and tactics, across multiple therapeutic areas and settings of care, to drive patient and provider confidence at launch and throughout a product’s lifecycle.

Before joining ADVI, Mary served as vice president, market access strategy at GSK, where she was responsible for trade and distribution, pricing and contracting, and aligned brand access strategy initiatives across the GSK product portfolio. Before GSK she was the vice president and head, US and global value, access and policy at MorphoSys. In this role, she was responsible for market access, reimbursement, government affairs, advocacy, and patient support in the US and globally for a newly launched oncology product. Mary has worked for numerous pharmaceutical companies including Biogen, Roche, and Eisai as well as spent over five years consulting with 1798 Consultants advising pharmaceutical and biotech companies on their access strategies. In addition to her time in market access, she has experience across the commercial teams in sales, marketing, and business development.

Mary holds a Master of Public Health in Health Services from Boston University and a Bachelor of Science in Biology from Boston College.